Cargando…
Integrative Hematology: State of the Art
Blood cancers are a group of diseases with thus far frequently poor prognosis. Although many new drugs, including target therapies, have been developed in recent years, there is still a need to expand our therapeutic armamentarium to better deal with these diseases. Integrative hematology was concei...
Autores principales: | Andreazzoli, Francesca, Bonucci, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864076/ https://www.ncbi.nlm.nih.gov/pubmed/36675247 http://dx.doi.org/10.3390/ijms24021732 |
Ejemplares similares
-
Vascular Access in Pediatric Oncology and Hematology: State of the Art
por: Crocoli, Alessandro, et al.
Publicado: (2022) -
Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the Art
por: Mollica, Veronica, et al.
Publicado: (2021) -
Common and Rare Hematological Manifestations and Adverse Drug Events during Treatment of Active TB: A State of Art
por: Minardi, Maria Letizia, et al.
Publicado: (2021) -
Cardiac Interventions in Patients With Active, Advanced Solid and Hematologic Malignancies: JACC: CardioOncology State-of-the-Art Review
por: Leong, Darryl P., et al.
Publicado: (2023) -
State of the Art of BIM Integration with Sensing Technologies in Construction Progress Monitoring
por: ElQasaby, Ahmed R., et al.
Publicado: (2022)